Loading clinical trials...
Loading clinical trials...
The purpose of this clinical study is to gather post-market clinical evidence on the use of the Biodesign® Dural and Duraplasty Grafts when used as a dura substitute of the dura mater.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cook Research Incorporated
NCT03276975 · Cerebrospinal Fluid Leaks
NCT03566602 · Cerebrospinal Fluid Leak
NCT04490629 · Cerebrospinal Fluid Leak
NCT04124523 · Cerebrospinal Fluid Leak
NCT02891070 · Cerebrospinal Fluid Leak
University of Alabama Birmingham Hospital
Birmingham, Alabama
Toronto Western Hospital
Toronto, Ontario
Ospedale Bellaria-Bolonga
Bologna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions